ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
US Tech 100
20,762.73
1.73%
Dow Jones
42,732.13
0.80%
Brent Oil
76.495
0.00%
Bitcoin
97,905.54
-0.31%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. CTP NV (CTPNV) Quote

CTP NV

CTP NV (CTPNV)

EU
14.92
-0.02
(-0.13%)
Closed January 05 11:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
14.92
Bid
14.84
Ask
15.40
Volume
93,640
14.88 Day's Range 15.08
14.10 52 Week Range 17.58
Market Cap
6.686B
Previous Close
14.94
Open
15.00
Last Trade
60
@
14.92
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
122,690
Shares Outstanding
448,154,000
Dividend Yield
-
PE Ratio
7.25
Earnings Per Share (EPS)
2.06
Revenue
684.2M
Net Profit
922.6M

About CTP NV

Sector
Real Estate Investment Trust
Industry
Real Estate Investment Trust
Website
www.ctp.eu
Headquarters
Amsterdam, North Holland, Nld
Founded
-
CTP NV is listed in the Real Estate Investment Trust sector of the Euronext with ticker CTPNV. The last closing price for CTP NV was 14.94 €. Over the last year, CTP NV shares have traded in a share price range of 14.10 € to 17.58 €.

CTP NV currently has 448,154,000 shares outstanding. The market capitalization of CTP NV is 6.70 € billion. CTP NV has a price to earnings ratio (PE ratio) of 7.25.

Ask ADVFN Intelligence (AI)

CTPNV Latest News

More News
No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.161.0840108401114.7615.0814.76547314.90750936DE
4-0.46-2.9908972691815.3815.5214.712200415.0617003DE
12-1.44-8.8019559902216.3617.114.112269015.28172198DE
26-1.16-7.2139303482616.0817.5814.110937615.86670636DE
52-0.18-1.1920529801315.117.5814.19818715.89523741DE
156-3.68-19.784946236618.619.39.2510552613.92713357DE
2600.876.1921708185114.0521.79.2510691414.69775724DE

CTPNV - Frequently Asked Questions (FAQ)

What is the current CTP NV share price?
The current share price of CTP NV is 14.92 €
How many CTP NV shares are in issue?
CTP NV has 448,154,000 shares in issue
What is the market cap of CTP NV?
The market capitalisation of CTP NV is EUR 6.7B
What is the 1 year trading range for CTP NV share price?
CTP NV has traded in the range of 14.10 € to 17.58 € during the past year
What is the PE ratio of CTP NV?
The price to earnings ratio of CTP NV is 7.25
What is the cash to sales ratio of CTP NV?
The cash to sales ratio of CTP NV is 9.77
What is the reporting currency for CTP NV?
CTP NV reports financial results in EUR
What is the latest annual turnover for CTP NV?
The latest annual turnover of CTP NV is EUR 684.2M
What is the latest annual profit for CTP NV?
The latest annual profit of CTP NV is EUR 922.6M
What is the registered address of CTP NV?
The registered address for CTP NV is APOLLOLAAN 151, AMSTERDAM, NORTH HOLLAND, 1077 AR
What is the CTP NV website address?
The website address for CTP NV is www.ctp.eu
Which industry sector does CTP NV operate in?
CTP NV operates in the REAL ESTATE INVESTMENT TRUST sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLFXOFinaxo
0.895 €
(43.20%)
500
MLWEYWeya
0.0175 €
(34.62%)
5.1k
POXELPoxel
0.191 €
(33.57%)
4.22M
ALBIOBiosynex
2.50 €
(28.73%)
50.71k
SEQUASequana medical NV
3.02 €
(23.27%)
1.05M
BNBSTonner Drones
0.0005 €
(-50.00%)
524.03k
ALAGOEPango SA
0.127 €
(-41.20%)
11.94M
EIFDSTour Eiffel DS
0.0032 €
(-38.46%)
33.94k
FINMFinanciere Marjos
0.076 €
(-36.13%)
1.4k
ALALOAcheterLouerFR
0.20 €
(-33.33%)
90.63k
ATOAtos SE
0.0024 €
(-4.00%)
1.53B
BCPBanco Comercial Portugues SA
0.4623 €
(0.74%)
43.69M
ALTDTonner Drones
0.0118 €
(-7.81%)
27.49M
NEOENNeoen SA
39.74 €
(-0.15%)
21.76M
ALVERVergnet
0.002 €
(0.00%)
16.8M

Discussion

View Full Feed
igotthemojo igotthemojo 18 minutes ago
i am speaking as the foremost authority on kblb that there is...bar none...i am saying that this stock is ready to fly...and will start flying BEFORE Feb...i have spoken...
KBLB
nowwhat2 nowwhat2 21 minutes ago
The Total 3

https://investorshub.advfn.com/uimage/uploads/2025/1/5/twljxtotal_3_!_5_5d_1212am_whump.jpg



Sho nuff.......Whump......Much of this is XRP but I'll betcya Doge, etc. SOL, too

https://investorshub.advfn.com/uimage/uploads/2025/1/
XRPUSD
boi568 boi568 28 minutes ago
That spike to $31.50 was not organic and it was clearly generated by a big player. I have always thought it was an engineered mini-short squeeze.
AVXL
Mr. Bill Mr. Bill 40 minutes ago
https://www.goodrx.com/well-being/sleep/how-to-sleep-with-sciatica
nowwhat2 nowwhat2 42 minutes ago
Could still just be climbing in sympathy w overall crypto mkt

Scathingly poor outlooks

https://www.youtube.com/watch?v=EOsjnOUAw14



https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

WONDF
DonVance DonVance 44 minutes ago
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 45 minutes ago
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 45 minutes ago
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 47 minutes ago
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 49 minutes ago
The Russes hit the jackpot?
BDEZ BDEZ 50 minutes ago
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 50 minutes ago
Not good, thanks for sharing.
sand sand 57 minutes ago
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 57 minutes ago
Moving hard soon 
EFSH
mining101 mining101 59 minutes ago
Superb
MEGL
benz280c benz280c 1 hour ago
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 1 hour ago
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 1 hour ago
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 1 hour ago
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 1 hour ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 1 hour ago
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 1 hour ago
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 1 hour ago
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL

Your Recent History

EU
CTPNV
CTP NV
COIN
ARAAGBP
Ara Token
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads